TUMOR NECROSIS FACTOR

TUMOR NECROSIS FACTOR Structure
CAS No.
Chemical Name:
TUMOR NECROSIS FACTOR
Synonyms
TSG6;α-induced protein 9;α-induced protein 6;TUMOR NECROSIS FACTOR;Anti-TSG6 antibody produced in rabbit;SixTransMembrane protein of prostate 2;Six-transmembrane epithelial antigen of prostate 4
CBNumber:
CB0816188
Molecular Formula:
Molecular Weight:
0
MOL File:
Mol file
Modify Date:
2023/3/21 13:45:01

TUMOR NECROSIS FACTOR Properties

storage temp. -20°C

TUMOR NECROSIS FACTOR Chemical Properties,Uses,Production

General Description

The TNFs (Etanercept, Enbrel) are members of a family ofcytokines that are produced primarily in the innate immunesystem by activated mononuclear phagocytes. Etanercept is a dimeric fusion protein consisting of the extracellularligand-binding portion of the human 75-kDa (p75)TNF receptor (TNFR) linked to the Fc portion of human isotypeIgG1. The Fc component of etanercept contains the CH2domain, the CH3 domain, and the hinge region, but not theCH1 domain of IgG1. These regions are responsible for thebiological effects of immunoglobulins. Each etanerceptmolecule binds specifically to two TNF molecules in the synovialfluid of rheumatoid arthritis patients. It is equally efficaciousat blocking TNFα and TNFβ. The drug is indicatedfor reducing signs and symptoms and inhibiting the progressionof structural damage in patients with moderately toseverely active rheumatoid arthritis. Etanercept is also indicatedfor reducing signs and symptoms of moderately toseverely active polyarticular-course juvenile rheumatoidarthritis in patients 4 years of age and older who have had aninadequate response to one or more disease-modifying antirheumaticdrugs (DMARDS). Etanercept is also indicatedfor reducing signs and symptoms of active arthritis in patientswith psoriatic arthritis.

Structure and conformation

TNF exists in two forms: a type II transmembrane protein (tmTNF) and a mature soluble protein (sTNF) . The TNF protein is first produced as tmTNF on the cell surface. tmTNF is enzymatically cleaved at its Ala76-Val77 site by TACE and is released as sTNF. sTNF forms a noncovalently bound homotrimer that is at least eight-fold more active than the monomer. The TNF monomer has 10 antiparallel β-sheets and exhibits a “jelly-roll” topology. Individual subunits form the trimer by an edge-to-face interaction of β-sheets. sTNF contains one disulfide bond (Cys69-Cys101), which plays a role in its biological functions.
Structure of TNF

TUMOR NECROSIS FACTOR Preparation Products And Raw materials

Raw materials

Preparation Products

TUMOR NECROSIS FACTOR Suppliers

Global( 10)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
MP Biomedicals, Inc. 949 833 2500 United States 6566 81 Inquiry
3B Pharmachem (Wuhan) International Co.,Ltd. 821-50328103-801 18930552037 China 15848 69 Inquiry
Riedel-de Haen AG 800 558-9160 United States 6825 87 Inquiry
United States Biological 1-800-520-3011 United States 6106 58 Inquiry
Shanghai yiji industries Co., Ltd. 021-60548335 China 6294 50 Inquiry
Nanjing Laifusai Biological Technology Co., Ltd. 400-9961-933 CHINA 6638 58 Inquiry
Shanghai Lianmai Biological Engineering Co., Ltd. 13052188602 CHINA 6700 58 Inquiry
Beijing Bolide Biotechnology Co., Ltd. 010-51653916 CHINA 6172 58 Inquiry
Shanghai Qunji Biological Technology Co., Ltd. 021-59771130 CHINA 6971 58 Inquiry
Sigma-Aldrich 021-61415566 800-8193336 China 51471 80 Inquiry
TUMOR NECROSIS FACTOR Six-transmembrane epithelial antigen of prostate 4 SixTransMembrane protein of prostate 2 α-induced protein 9 Anti-TSG6 antibody produced in rabbit TSG6 α-induced protein 6